While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Study underscores the direct vascular effects of this class of drugs, researchers say AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) ...

As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...

Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase 2 Trial results, highlighting its dual mechanism of action and rapid ...

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...